Aims and scope

Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.

Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid, and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.

Reasons to publish

• Latest Impact Factor 5.267
• The premier global forum for basic, translational and clinical research on hormones and cancer
• Fast publication: mean receipt to first response is 13 days
• Accepted preprints, published online and fully citable within 24 hours of acceptance
• Published continuously online as soon as version of record is available i.e. just weeks from acceptance
• No submission fees or page charges

Article types

Reviews and original research papers of exceptional quality are considered. Case reports are only considered if they are of extraordinary interest and reveal a new mechanism of disease. Please see our Instructions for authors for further information.

Editorial Board

Endocrine-Related Cancer has an international Editorial board with expertise across different branches of clinical endocrinology.

Abstracting and indexing

Endocrine-Related Cancer is indexed in: Chemical Abstracts, Current Content/Clinical Medicine, EMBASE/Excerpta Medica, Index Medicus/MEDLINE, Science Citation Index, Science Citation Index Expanded, Scopus.

Terms and Conditions

Terms and conditions for online acess to full text of Society for Endocrinology journals apply.

Notification of latest content

Keep up-to-date with the latest news from Endocrine-Related Cancer by signing up to receive email newsletters, sent on a bimonthly basis. You can also register for Table of Contents alerts, opting to receive notification of new issues or new articles.